ARCHIVES

FDA News: FDA Taking Comments on “First Generic” ANDA Process

This article is from The Cancer Letter archive.

Vol. 40 No. 44 | November 21, 2014

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI Last Month Are Listed

February 28, 2003

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

In Brief: King Named To Replace Saunders; Zubrod Retires, Will Go To Miami; Perry acting Treatment Chief

June 14, 1974

In Brief: Evaluation Of Potential Immunoassay Components Sought; Promising Results Could Lead to Contract

September 19, 1975

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

March 25, 2011

High Radiation Dose Effective Ten Years After Treatment

November 28, 2003